| Literature DB >> 35123395 |
Flavia Cristina Drumond Andrade1, Nekehia T Quashie2, Luisa Farah Schwartzman3.
Abstract
BACKGROUND: Brazil is among the countries hit hardest by COVID-19, and older adults are among the vulnerable groups. Intergenerational coresidence and interdependence among family members, both prevalent in Brazil, likely increase social and physical contact and thus potential infection.Entities:
Keywords: Brazil; COVID-19 symptoms; Living arrangements; Older adults
Mesh:
Year: 2022 PMID: 35123395 PMCID: PMC8817777 DOI: 10.1186/s12877-022-02800-6
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Characteristics of participants aged 60 and older of the COVID-19 PNAD, by living arrangements, July 2020
| Total | Older adults alone (14.1%) | Older adults only (29.1%) | Multigenerational (14.5%) | Skipped generation (2.2%) | Adults and older adults only (40%) | ||
|---|---|---|---|---|---|---|---|
| Mean household size | 2.7 | 1.0 | 2.1 | 4.8 | 2.9 | 3.0 | < 0.0001 |
| Mean age | 70.1 | 71.6 | 70.6 | 69.1 | 67.9 | 69.6 | < 0.0001 |
| Female (%) | 55.9 | 68.9 | 52.1 | 55.3 | 62.1 | 54.0 | < 0.0001 |
| Race (%) | < 0.0001 | ||||||
| White | 51.6 | 55.0 | 59.6 | 39.7 | 35.2 | 49.9 | |
| Black | 8.2 | 8.0 | 6.1 | 11.3 | 8.8 | 8.5 | |
| Brown | 38.7 | 35.7 | 32.7 | 47.7 | 54.6 | 40.0 | |
| Indigenous | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.2 | |
| Other | 1.2 | 1.0 | 1.4 | 0.8 | 1.0 | 1.3 | |
| Education (%) | < 0.0001 | ||||||
| Without schooling | 13.1 | 11.9 | 10.3 | 18.7 | 17.8 | 13.2 | |
| Less than HS | 56.1 | 54.6 | 56.0 | 58.4 | 64.8 | 55.4 | |
| HS complete | 18.3 | 18.5 | 18.7 | 15.8 | 12.0 | 19.1 | |
| College or more | 12.6 | 15.0 | 15.0 | 7.1 | 5.4 | 12.3 | |
| Household per capita income quartile (%) | < 0.0001 | ||||||
| 1 | 12.7 | 2.9 | 6.4 | 35.6 | 38.1 | 11.0 | |
| 2 | 19.4 | 3.3 | 11.6 | 33.6 | 36.1 | 24.7 | |
| 3 | 39.0 | 49.2 | 50.1 | 20.3 | 18.6 | 35.3 | |
| 4 | 28.9 | 44.6 | 32.0 | 10.5 | 7.2 | 29.0 | |
| Region (%) | < 0.0001 | ||||||
| North | 5.3 | 3.7 | 3.6 | 10.5 | 10.0 | 5.1 | |
| Northeast | 24.1 | 19.9 | 19.2 | 31.8 | 36.1 | 25.6 | |
| Southeast | 47.4 | 51.9 | 50.2 | 38.6 | 35.9 | 47.6 | |
| South | 16.7 | 18.3 | 21.0 | 11.8 | 10.4 | 15.0 | |
| Center West | 6.5 | 6.2 | 5.9 | 7.3 | 7.8 | 6.7 | |
| Urban (%) | 86.4 | 89.7 | 84.5 | 85.0 | 80.2 | 87.4 | < 0.0001 |
| Health conditions (%) | |||||||
| Diabetes | 20.9 | 21.4 | 21.1 | 20.5 | 24.3 | 20.4 | 0.0461 |
| Hypertension | 46.1 | 50.0 | 45.3 | 45.9 | 47.2 | 45.3 | < 0.0001 |
| Heart disease | 11.0 | 12.8 | 11.5 | 9.5 | 9.3 | 10.6 | < 0.0001 |
| Asthma | 6.0 | 8.3 | 5.7 | 5.5 | 6.0 | 5.6 | < 0.0001 |
| Cancer | 3.9 | 4.9 | 4.3 | 2.9 | 2.5 | 3.7 | < 0.0001 |
| Depression | 5.5 | 9.2 | 5.3 | 4.3 | 4.5 | 4.9 | < 0.0001 |
| Proxy respondents (%) | 57.7 | 20.4 | 56.5 | 74.3 | 48.9 | 66.2 | < 0.0001 |
Source: Authors’ calculations using data from the COVID-19 PNAD, July. Weighted estimates
Fig. 1Trends in reported COVID-19 symptoms, testing, and positive cases among older adults in Brazil, July–November 2020
Adjusted Prevalence Ratios and 95% confidence intervals (CI) for factors associated with the reporting of COVID-19 symptoms, testing and receiving a positive result, older adults, Brazil (July–November)
| Symptoms | Testing | Positive | ||||
|---|---|---|---|---|---|---|
| PR | 95% CI | PR | 95% CI | PR | 95% CI | |
| Living arrangement (versus older adult alone) | ||||||
| Older adults only | 0.726*** | (0.68, 0.77) | 0.910 | (0.82, 1.01) | 1.013 | (0.80, 1.29) |
| Multigenerational | 0.722*** | (0.67, 0.78) | 0.815*** | (0.73, 0.92) | 1.532** | (1.15, 2.04) |
| Skipped generation | 0.775*** | (0.68, 0.88) | 0.729** | (0.60, 0.89) | 1.607* | (1.04, 2.48) |
| Adults and older adults | 0.735*** | (0.69, 0.78) | 0.945 | (0.86, 1.04) | 1.269* | (1.00, 1.61) |
| Age (in years) | 1.000 | (1.00, 1.00) | 0.984*** | (0.98, 0.99) | 0.975*** | (0.97, 0.98) |
| Female (versus male) | 1.019 | (0.98, 1.06) | 0.913** | (0.86, 0.98) | 0.882 | (0.75, 1.03) |
| Race (versus White) | ||||||
| Black | 1.088* | (1.01, 1.17) | 0.945 | (0.84, 1.07) | 0.929 | (0.70, 1.24) |
| Brown | 1.091*** | (1.04, 1.14) | 0.925* | (0.86, 0.99) | 1.138 | (0.96, 1.35) |
| Indigenous | 1.493** | (1.13, 1.97) | 1.813** | (1.21, 2.71) | 1.895 | (0.48, 7.55) |
| Other | 1.011 | (0.81, 1.26) | 0.921 | (0.68, 1.25) | 0.496 | (0.22, 1.12) |
| Education (versus no schooling) | ||||||
| Less than high school | 0.969 | (0.91, 1.03) | 1.082 | (0.98, 1.20) | 1.200 | (0.97, 1.49) |
| High school complete | 0.892** | (0.83, 0.96) | 1.579*** | (1.40, 1.78) | 1.942*** | (1.47, 2.56) |
| College or more | 0.839*** | (0.77, 0.92) | 2.561*** | (2.26, 2.90) | 2.594*** | (1.86, 3.61) |
| Per capita household quartile (versus 1st) | ||||||
| 2 | 0.972 | (0.92, 1.02) | 1.029 | (0.97, 1.09) | 1.066 | (0.94, 1.20) |
| 3 | 0.953 | (0.90, 1.01) | 1.174*** | (1.10, 1.25) | 1.255** | (1.09, 1.45) |
| 4 | 0.895*** | (0.84, 0.96) | 1.464*** | (1.36, 1.57) | 1.541*** | (1.31, 1.82) |
| Region (versus North) | ||||||
| Northeast | 0.893** | (0.83, 0.96) | 0.819*** | (0.73, 0.92) | 0.345*** | (0.24, 0.50) |
| Southeast | 0.781*** | (0.73, 0.84) | 0.435*** | (0.39, 0.49) | 0.112*** | (0.08, 0.16) |
| South | 0.916* | (0.84, 0.99) | 0.345*** | (0.30, 0.39) | 0.0778*** | (0.05, 0.11) |
| Center West | 0.972 | (0.89, 1.06) | 0.948 | (0.84, 1.07) | 0.466*** | (0.30, 0.72) |
| Urban (versus rural) | 1.016 | (0.97, 1.07) | 2.492*** | (2.24, 2.77) | 2.404*** | (1.98, 2.92) |
| Health conditions (versus none) | ||||||
| Diabetes | 1.236*** | (1.18, 1.29) | 1.227*** | (1.15, 1.31) | 1.538*** | (1.33, 1.78) |
| Hypertension | 1.267*** | (1.22, 1.32) | 1.115*** | (1.06, 1.17) | 1.324*** | (1.18, 1.48) |
| Heart disease | 1.494*** | (1.42, 1.57) | 1.330*** | (1.24, 1.42) | 1.253** | (1.06, 1.48) |
| Asthma | 1.998*** | (1.89, 2.12) | 1.552*** | (1.44, 1.68) | 1.495*** | (1.22, 1.83) |
| Cancer | 1.364*** | (1.25, 1.48) | 1.228*** | (1.10, 1.36) | 1.284 | (0.98, 1.69) |
| Depression | 1.771*** | (1.67, 1.88) | 1.237*** | (1.14, 1.34) | 1.468*** | (1.20, 1.80) |
| Proxy respondent (versus no) | 0.608*** | (0.58, 0.63) | 0.934*** | (0.90, 0.97) | 1.024 | (0.94, 1.12) |
| Month (versus July) | ||||||
| August | 0.888*** | (0.86, 0.92) | 1.389*** | (1.35, 1.43) | 1.513*** | (1.41, 1.62) |
| September | 0.735*** | (0.71, 0.77) | 1.739*** | (1.69, 1.79) | 1.949*** | (1.82, 2.09) |
| October | 0.735*** | (0.57, 0.63) | 2.068*** | (2.00, 2.14) | 2.266*** | (2.11, 2.43) |
| November | 0.599*** | (0.58, 0.63) | 2.331*** | (2.26, 2.41) | 2.496*** | (2.32, 2.68) |
| Constant | 0.605*** | (0.05, 0.07) | 0.007*** | (0.00, 0.01) | 0.000*** | (0.00, 0.00) |
| Random ID | 1.147 | (1.10, 1.20) | 6.783 | (6.65, 6.92) | 11.247 | (10.83, 11.68) |
Source: Authors’ calculations using data from the COVID-19 PNAD, July–November. Robust standard errors have been estimated and account for the clustering of data on individuals
Note: * p < 0.05, ** p < 0.01, *** p < 0.001, 95% CI: 95% confidence interval
Adjusted prevalence ratios and 95% confidence intervals (CI) for factors associated with the reporting of COVID-19 testing and receiving a positive result, Brazil
| Testing (M1) | Testing (M2) | Positive (M1) | Positive (M2) | |||||
|---|---|---|---|---|---|---|---|---|
| PR | 95% CI | PR | 95% CI | PR | 95% CI | PR | 95% CI | |
| Living arrangement (versus older adult alone) | ||||||||
| Older adults only | 0.921 | (0.83, 1.02) | 0.902* | (0.81, 1.00) | 1.021 | (0.81, 1.29) | 1.012 | (0.80, 1.29) |
| Multigenerational | 0.821*** | (0.73, 0.92) | 0.799*** | (0.71, 0.90) | 1.522** | (1.16, 2.00) | 1.506** | (1.14, 2.00) |
| Skipped generation | 0.743** | (0.61, 0.90) | 0.721** | (0.59, 0.88) | 1.634* | (1.06, 2.51) | 1.587* | (1.02, 2.48) |
| Adults and older adults | 0.955 | (0.87, 1.05) | 0.930 | (0.84, 1.02) | 1.292* | (1.03, 1.63) | 1.265 | (1.00, 1.60) |
| Symptoms | 1.734*** | (1.68, 1.79) | 1.472*** | (1.37, 1.58) | 2.357*** | (2.21, 2.52) | 2.133*** | (1.82, 2.50) |
| Interactions | ||||||||
| Symptoms*older adults only | 1.164** | (1.06, 1.28) | 1.064 | (0.87, 1.30) | ||||
| Symptoms*Multigenerational | 1.243*** | (1.12, 1.38) | 1.078 | (0.87, 1.33) | ||||
| Symptoms*Skipped generation | 1.281* | (1.05, 1.56) | 1.184 | (0.89, 1.58) | ||||
| Symptoms*Adults and older adults | 1.250*** | (1.15, 1.36) | 1.170 | (0.98, 1.40) | ||||
| Age (in years) | 0.984*** | (0.98, 0.99) | 0.984*** | (0.98, 0.99) | 0.976*** | (0.97, 0.99) | 0.976*** | (0.97, 0.99) |
| Female (versus male) | 0.911** | (0.85, 0.97) | 0.911** | (0.85, 0.97) | 0.882 | (0.76, 1.03) | 0.882 | (0.76, 1.03) |
| Race (versus White) | ||||||||
| Black | 0.946 | (0.84, 1.07) | 0.946 | (0.84, 1.07) | 0.931 | (0.71, 1.23) | 0.931 | (0.71, 1.23) |
| Brown | 0.925* | (0.86, 0.99) | 0.925* | (0.86, 0.99) | 1.129 | (0.96, 1.33) | 1.129 | (0.96, 1.33) |
| Indigenous | 1.780** | (1.19, 2.67) | 1.778** | (1.18, 2.67) | 1.783 | (0.49, 6.48) | 1.784 | (0.49, 6.48) |
| Other | 0.938 | (0.69, 1.27) | 0.938 | (0.69, 1.27) | 0.503 | (0.23, 1.11) | 0.503 | (0.23, 1.11) |
| Education (versus no schooling) | ||||||||
| Less than high school | 1.081 | (0.98, 1.20) | 1.080 | (0.97, 1.20) | 1.201 | (0.97, 1.48) | 1.200 | (0.97, 1.48) |
| High school complete | 1.576*** | (1.40, 1.78) | 1.574*** | (1.40, 1.77) | 1.948*** | (1.49, 2.54) | 1.945*** | (1.49, 2.54) |
| College or more | 2.558*** | (2.26, 2.89) | 2.556*** | (2.26, 2.89) | 2.536*** | (1.85, 3.47) | 2.534*** | (1.85, 3.47) |
| Per capita household quartile (versus 1st) | ||||||||
| 2 | 1.033 | (0.97, 1.09) | 1.033 | (0.97, 1.09) | 1.088 | (0.96, 1.23) | 1.087 | (0.96, 1.23) |
| 3 | 1.179*** | (1.10, 1.26) | 1.178*** | (1.10, 1.26) | 1.264** | (1.09, 1.46) | 1.264** | (1.09, 1.46) |
| 4 | 1.469*** | (1.37, 1.58) | 1.469*** | (1.37, 1.58) | 1.558*** | (1.32, 1.83) | 1.554*** | (1.32, 1.83) |
| Region (versus North) | ||||||||
| Northeast | 0.825*** | (0.74, 0.92) | 0.825*** | (0.74, 0.92) | 0.369*** | (0.26, 0.51) | 0.369*** | (0.26, 0.51) |
| Southeast | 0.442*** | (0.39, 0.49) | 0.442*** | (0.39, 0.49) | 0.123*** | (0.09, 0.17) | 0.123*** | (0.09, 0.17) |
| South | 0.348*** | (0.31, 0.40) | 0.349*** | (0.31, 0.40) | 0.0846*** | (0.06, 0.12) | 0.0847*** | (0.06, 0.12) |
| Center West | 0.948 | (0.84, 1.07) | 0.948 | (0.84, 1.07) | 0.479*** | (0.32, 0.71) | 0.479*** | (0.32, 0.71) |
| Urban (versus rural) | 2.458*** | (2.22, 2.73) | 2.457*** | (2.22, 2.72) | 2.333*** | (1.93, 2.82) | 2.332*** | (1.93, 2.82) |
| Health conditions (versus none) | ||||||||
| Diabetes | 1.214*** | (1.14, 1.29) | 1.213*** | (1.14, 1.29) | 1.478*** | (1.28, 1.71) | 1.479*** | (1.28, 1.71) |
| Hypertension | 1.106*** | (1.05, 1.16) | 1.106*** | (1.05, 1.16) | 1.319*** | (1.18, 1.47) | 1.320*** | (1.18, 1.47) |
| Heart disease | 1.310*** | (1.22, 1.40) | 1.310*** | (1.23, 1.40) | 1.229* | (1.04, 1.45) | 1.231* | (1.04, 1.45) |
| Asthma | 1.503*** | (1.39, 1.62) | 1.505*** | (1.39, 1.63) | 1.479*** | (1.21, 1.81) | 1.484*** | (1.22, 1.81) |
| Cancer | 1.219*** | (1.10, 1.36) | 1.221*** | (1.10, 1.36) | 1.298 | (0.99, 1.70) | 1.302 | (0.99, 1.71) |
| Depression | 1.211*** | (1.11, 1.32) | 1.211*** | (1.11, 1.32) | 1.404** | (1.15, 1.72) | 1.404** | (1.15, 1.72) |
| Proxy respondent (versus no) | 0.945** | (0.91, 0.98) | 0.946** | (0.91, 0.98) | 1.042 | (0.95, 1.14) | 1.040 | (0.95, 1.14) |
| Month (versus July) | ||||||||
| August | 1.408*** | (1.37, 1.45) | 1.409*** | (1.37, 1.45) | 1.584*** | (1.48, 1.69) | 1.585*** | (1.48, 1.69) |
| September | 1.795*** | (1.74, 1.85) | 1.797*** | (1.74, 1.85) | 2.121*** | (1.98, 2.27) | 2.124*** | (1.98, 2.28) |
| October | 2.167*** | (2.10, 2.24) | 2.169*** | (2.10, 2.24) | 2.579*** | (2.40, 2.77) | 2.581*** | (2.40, 2.77) |
| November | 2.450*** | (2.37, 2.53) | 2.453*** | (2.37, 2.53) | 2.909*** | (2.70, 3.13) | 2.912*** | (2.70, 3.14) |
| Constant | 0.001*** | (0.00, 0.01) | 0.007*** | (0.00, 0.01) | 0.000*** | (0.00, 0.00) | 0.001*** | (0.00, 0.00) |
| Random ID | 6.577 | (6.44, 6.72) | 6.571 | (6.43, 6.71) | 10.651 | (10.25, 11.07) | 10.648 | (10.25, 11.07) |
Source: Authors’ calculations using data from the COVID-19 PNAD, July–November. Robust standard errors have been estimated and account for the clustering of data on individuals
Note: * p < 0.05, ** p < 0.01, *** p < 0.001, 95% CI: 95% confidence interval
Fig. 2Predicted probabilities of testing among older adults by living arrangements and reporting of symptoms in Brazil, July–November 2020
Adjusted odds ratios and 95% confidence intervals (CI) for factors associated with the cumulative reporting of COVID-19 symptoms, testing and receiving a positive result, older adults, Brazil
| Symptoms | Testing | Positive | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | OR | 95% CI | OR | 95% CI | |
| Living arrangement (versus older adult alone) | ||||||
| Older adults only | 0.737*** | (0.69, 0.79) | 0.958 | (0.88, 1.04) | 1.073 | (0.90, 1.28) |
| Multigenerational | 0.705*** | (0.65, 0.77) | 0.828*** | (0.75, 0.91) | 1.275* | (1.05, 1.55) |
| Skipped generation | 0.774*** | (0.67, 0.89) | 0.789** | (0.67, 0.94) | 1.459* | (1.08, 1.96) |
| Adults and older adults | 0.724*** | (0.68, 0.78) | 0.937 | (0.86, 1.02) | 1.196* | (1.01, 1.42) |
| Age (in years) | 0.999 | (1.00, 1.00) | 0.991*** | (0.99, 0.99) | 0.986*** | (0.98, 0.99) |
| Female (versus male) | 1.033 | (0.99, 1.08) | 0.946* | (0.90, 0.99) | 0.938 | (0.86, 1.03) |
| Race (versus White) | ||||||
| Black | 1.103* | (1.02, 1.20) | 0.990 | (0.90, 1.08) | 0.973 | (0.81, 1.17) |
| Brown | 1.081** | (1.03, 1.13) | 0.978 | (0.93, 1.03) | 1.067 | (0.96, 1.18) |
| Indigenous | 1.609** | (1.15, 2.24) | 1.427* | (1.00, 2.03) | 1.502 | (0.82, 2.75) |
| Other | 1.069 | (0.85, 1.35) | 0.941 | (0.73, 1.21) | 0.655 | (0.36, 1.20) |
| Education (versus no schooling) | ||||||
| Less than HS | 0.977 | (0.92, 1.04) | 1.049 | (0.97, 1.13) | 1.088 | (0.94, 1.26) |
| HS complete | 0.905* | (0.84, 0.98) | 1.285*** | (1.18, 1.41) | 1.417*** | (1.19, 1.69) |
| College or more | 0.839*** | (0.76, 0.92) | 1.705*** | (1.55, 1.88) | 1.456*** | (1.20, 1.77) |
| Per capita household quartile (versus 1st) | ||||||
| 2 | 0.970 | (0.91, 1.03) | 0.952 | (0.88, 1.03) | 1.031 | (0.88, 1.20) |
| 3 | 0.958 | (0.90, 1.02) | 1.130** | (1.05, 1.22) | 1.257** | (1.08, 1.47) |
| 4 | 0.894** | (0.83, 0.96) | 1.426*** | (1.32, 1.54) | 1.564*** | (1.33, 1.84) |
| Region (versus North) | ||||||
| Northeast | 0.850*** | (0.78, 0.92) | 0.871** | (0.80, 0.95) | 0.623*** | (0.54, 0.72) |
| Southeast | 0.746*** | (0.69, 0.81) | 0.590*** | (0.54, 0.64) | 0.334*** | (0.29, 0.39) |
| South | 0.879** | (0.81, 0.96) | 0.525*** | (0.48, 0.58) | 0.259*** | (0.22, 0.31) |
| Center West | 0.950 | (0.86, 1.04) | 0.960 | (0.87, 1.06) | 0.693*** | (0.59, 0.82) |
| Rural (versus urban) | 0.952 | (0.90, 1.00) | 0.589*** | (0.55, 0.63) | 0.609*** | (0.53, 0.70) |
| Health conditions (versus none) | ||||||
| Diabetes | 1.217*** | (1.16, 1.28) | 1.125*** | (1.06, 1.19) | 1.281*** | (1.15, 1.43) |
| Hypertension | 1.210*** | (1.16, 1.26) | 1.043 | (0.99, 1.09) | 1.175*** | (1.07, 1.29) |
| Heart disease | 1.437*** | (1.35, 1.53) | 1.437*** | (1.06, 1.23) | 1.097 | (0.95, 1.27) |
| Asthma | 2.099*** | (1.95, 2.26) | 1.355*** | (1.24, 1.48) | 1.231* | (1.03, 1.48) |
| Cancer | 1.300*** | (1.17, 1.44) | 1.173** | (1.05, 1.32) | 1.142 | (0.91, 1.44) |
| Depression | 1.767*** | (1.63, 1.91) | 1.157** | (1.05, 1.28) | 1.229* | (1.01, 1.49) |
| Proxy respondent (versus no) | 0.665*** | (0.64, 0.70) | 0.928** | (0.88, 0.98) | 0.964 | (0.87, 1.06) |
| Constant | 0.37 | (0.30, 0.47) | 0.05 | (0.31, 0.52) | 0.10 | (0.06, 0.17) |
Source: Authors’ calculations using data from the COVID-19 PNAD, cumulative July–November. Robust standard errors
Note: * p < 0.05, ** p < 0.01, *** p < 0.001, 95% CI: 95% confidence interval
Adjusted Odds Ratios and 95% confidence intervals (CI) for factors associated with the cumulative reporting of COVID-19 testing and receiving a positive result, Brazil (n = 63,268)
| Testing (Model 1) | Testing (Model 2) | Positive (Model 1) | Positive (Model 2) | |||||
|---|---|---|---|---|---|---|---|---|
| PR | 95% CI | PR | 95% CI | PR | 95% CI | PR | 95% CI | |
| Living arrangement (versus older adult alone) | ||||||||
| Older adults only | 1.023 | (0.94, 1.11) | 0.919 | (0.83, 1.01) | 1.221* | (1.02, 1.47) | 0.920 | (0.71, 1.19) |
| Multigenerational | 0.882* | (0.80, 0.98) | 0.764*** | (0.68, 0.86) | 1.455*** | (1.19, 1.78) | 1.241 | (0.95, 1.63) |
| Skipped generation | 0.828* | (0.70, 0.98) | 0.702** | (0.57, 0.87) | 1.629** | (1.20, 2.20) | 1.209 | (0.77, 1.91) |
| Adults and older adults | 0.999 | (0.92, 1.09) | 0.897* | (0.81, 0.99) | 1.358*** | (1.14, 1.62) | 1.089 | (0.85, 1.40) |
| Symptoms | 2.832*** | (2.69, 2.98) | 2.184*** | (1.92, 2.48) | 5.852*** | (5.32, 6.44) | 4.167*** | (3.14, 5.53) |
| Interactions | ||||||||
| Symptoms*older adults only | 1.328*** | (1.13, 1.56) | 1.632** | (1.16, 2.29) | ||||
| Symptoms*multigenerational | 1.515*** | (1.26, 1.83) | 1.266 | (0.89, 1.80) | ||||
| Symptoms*skipped generation | 1.560* | (1.09, 2.22) | 1.662 | (0.91, 3.03) | ||||
| Symptoms*adults and older adults | 1.327*** | (1.14, 1.54) | 1.447* | (1.06, 1.98) | ||||
| Age (in years) | 0.991*** | (0.99, 0.99) | 0.991*** | (0.99, 0.99) | 0.987*** | (0.98, 0.99) | 0.987*** | (0.98, 0.99) |
| Female (versus male) | 0.937** | (0.89, 0.98) | 0.936** | (0.89, 0.98) | 0.921 | (0.84, 1.01) | 0.921 | (0.84, 1.01) |
| Race (versus White) | ||||||||
| Black | 0.974 | (0.89, 1.07) | 0.975 | (0.89, 1.07) | 0.942 | (0.78, 1.13) | 0.942 | (0.78, 1.13) |
| Brown | 0.965 | (0.91, 1.02) | 0.964 | (0.91, 1.02) | 1.042 | (0.94, 1.16) | 1.040 | (0.94, 1.16) |
| Indigenous | 1.305 | (0.91, 1.88) | 1.294 | (0.90, 1.87) | 1.231 | (0.66, 2.28) | 1.225 | (0.66, 2.27) |
| Other | 0.932 | (0.72, 1.20) | 0.932 | (0.72, 1.20) | 0.651 | (0.36, 1.18) | 0.653 | (0.36, 1.18) |
| Education (versus no schooling) | ||||||||
| Less than HS | 1.057 | (0.98, 1.14) | 1.057 | (0.98, 1.14) | 1.103 | (0.95, 1.28) | 1.104 | (0.95, 1.28) |
| HS complete | 1.319*** | (1.21, 1.44) | 1.319*** | (1.20, 1.44) | 1.478*** | (1.24, 1.76) | 1.478*** | (1.24, 1.76) |
| College or more | 1.794*** | (1.62, 1.98) | 1.792*** | (1.62, 1.98) | 1.581*** | (1.29, 1.93) | 1.584*** | (1.30, 1.94) |
| Per capita household quartile (versus 1st) | ||||||||
| 2 | 0.959 | (0.89, 1.04) | 0.956 | (0.88, 1.03) | 1.048 | (0.89, 1.23) | 1.046 | (0.89, 1.23) |
| 3 | 1.149*** | (1.06, 1.24) | 1.146*** | (1.06, 1.24) | 1.302** | (1.11, 1.53) | 1.300** | (1.11, 1.52) |
| 4 | 1.476*** | (1.36, 1.60) | 1.473*** | (1.36, 1.60) | 1.667*** | (1.41, 1.97) | 1.669*** | (1.41, 1.97) |
| Region (versus North) | ||||||||
| Northeast | 0.890** | (0.82, 0.97) | 0.889** | (0.82, 0.97) | 0.640*** | (0.55, 0.74) | 0.640*** | (0.55, 0.74) |
| Southeast | 0.612*** | (0.56, 0.67) | 0.612*** | (0.56, 0.67) | 0.355*** | (0.30, 0.41) | 0.355*** | (0.30, 0.41) |
| South | 0.524*** | (0.48, 0.58) | 0.524*** | (0.48, 0.58) | 0.255*** | (0.21, 0.31) | 0.254*** | (0.21, 0.31) |
| Center West | 0.966 | (0.88, 1.07) | 0.967 | (0.88, 1.07) | 0.690*** | (0.58, 0.82) | 0.690*** | (0.58, 0.82) |
| Rural (versus urban) | 0.587*** | (0.55, 0.63) | 0.587*** | (0.55, 0.63) | 0.612*** | (0.54, 0.70) | 0.612*** | (0.53, 0.70) |
| Health conditions (versus none) | ||||||||
| Diabetes | 1.087** | (1.03, 1.15) | 1.087** | (1.03, 1.15) | 1.198** | (1.07, 1.34) | 1.198** | (1.07, 1.34) |
| Hypertension | 1.010 | (0.96, 1.06) | 1.010 | (0.96, 1.06) | 1.103* | (1.00, 1.22) | 1.103* | (1.00, 1.22) |
| Heart disease | 1.060 | (0.98, 1.14) | 1.061 | (0.98, 1.14) | 1.060 | (0.82, 1.11) | 0.954 | (0.82, 1.11) |
| Asthma | 1.167** | (1.06, 1.28) | 1.172*** | (1.07, 1.29) | 0.937 | (0.78, 1.13) | 0.937 | (0.78, 1.13) |
| Cancer | 1.119 | (1.00, 1.26) | 1.122 | (1.00, 1.26) | 1.044 | (0.83, 1.32) | 1.047 | (0.83, 1.32) |
| Depression | 1.022 | (0.92, 1.13) | 1.027 | (0.93, 1.14) | 0.979 | (0.80, 1.20) | 0.980 | (0.80, 1.20) |
| Proxy respondent (versus no) | 0.997 | (0.95, 1.05) | 1.000 | (0.95, 1.05) | 1.119* | (1.01, 1.24) | 1.120* | (1.01, 1.24) |
| Constant | 0.280 | (0.21, 0.37) | 0.311 | (0.24, 0.41) | 0.046 | (0.03, 0.08) | 0.057 | (0.03, 0.10) |
Source: Authors’ calculations using data from the COVID-19 PNAD, cumulative July–November. Robust standard errors
Note: * p < 0.05, ** p < 0.01, *** p < 0.001, 95% CI: 95% confidence interval